This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Valmont (VMI) Buys Walpar, Expands in Sign Structures Market
by Zacks Equity Research
The acquisition strengthens Valmont's (VMI) foothold in the sign structures market.
Koppers (KOP) Earnings & Revenues Trail Estimates in Q2
by Anindya Barman
Koppers (KOP) reaffirmed its adjusted earnings guidance at the range of $4.05 and $4.25 per share for 2018.
Andersons (ANDE) Q2 Earnings Top, Revenues Miss Estimates
by Zacks Equity Research
Andersons (ANDE) anticipated to benefit from strong domestic and export demand despite the impact of current tariffs and trade disputes.
Valmont (VMI) Buys Derit, Enters Lattice Structures Market
by Zacks Equity Research
Valmont (VMI) is poised to benefit from Derit's 40,000 metric tons of lattice manufacturing capacity.
Kronos Worldwide (KRO) Lags Q2 Earnings & Sales Estimates
by Zacks Equity Research
Lower TiO2 production and sales volumes on a year-over-year basis hurt Kronos Worldwide's (KRO) Q2 earnings.
Albemarle (ALB) Looks Good: Stock Adds 6.4% in Session
by Zacks Equity Research
Albemarle (ALB) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
American Vanguard (AVD) Q2 Earnings Top, Sales Miss Estimates
by Anindya Barman
American Vanguard (AVD) sees strong performance across a number of major components of its business through the remainder of 2018.
Innospec (IOSP) Q2 Earnings Miss Estimates, Sales Up Y/Y
by Zacks Equity Research
While Innospec (IOSP) saw higher sales across its core business units in Q2, its earnings miss expectations.
Versum Materials (VSM) Q3 Earnings & Revenues Top Estimates
by Zacks Equity Research
Versum Materials (VSM) has narrowed its total sales and adjusted EBITDA guidance for fiscal 2018.
Albemarle (ALB) Tops Q2 Earnings Estimates, Raises FY18 View
by Anindya Barman
Albemarle (ALB) raised its adjusted earnings outlook for 2018 to $5.30-$5.50 per share.
Cabot (CBT) Earnings and Revenues Trump Estimates in Q3
by Zacks Equity Research
Cabot (CBT) expects strong performance across all segments in Q4.
Kinross (KGC) Q2 Earnings In Line, Revenues Miss Estimates
by Zacks Equity Research
Lower production and a decrease in gold equivalent ounces sold impacts Kinross' (KGC) performance in Q2.
Mosaic's (MOS) Q2 Earnings Beat Estimates, FY18 View Up
by Anindya Barman
Mosaic (MOS) bumped up its adjusted earnings guidance for 2018 to $1.45-$1.80 per share.
Scotts Miracle-Gro (SMG) Q3 Earnings Top, Sales Lag Estimates
by Zacks Equity Research
Scotts Miracle-Gro (SMG) reiterates its adjusted earnings outlook for fiscal 2018 in the range of $3.70-$3.90 per share.
Platform Specialty (PAH) Q2 Earnings & Revenues Top Estimates
by Zacks Equity Research
Platform Specialty (PAH) is focused on finalizing its restructuring plans over the remainder of 2018.
Chemours (CC) Earnings, Revenues Trump Estimates in Q2
by Anindya Barman
Chemours (CC) topped expectations in Q2 on strong results across its business segments.
Are Investors Undervaluing Celanese (CE) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
LyondellBasell (LYB) Tops Earnings & Sales Estimates in Q2
by Zacks Equity Research
Despite year-over-year decline in Olefins & Polyolefins margins, LyondellBasell's (LYB) Q2 earnings surpass expectations.
Westlake's (WLK) Earnings Miss, Revenues Top Estimates in Q2
by Zacks Equity Research
Westlake (WLK) is seeing strong demand for its products across its segments.
Zacks.com featured highlights include: Celgene, Progressive, T. Rowe Price, AMC and Celanese
by Zacks Equity Research
Zacks.com featured highlights include: Celgene, Progressive, T. Rowe Price, AMC and Celanese
U.S. Steel (X) Beats Q2 Earnings Estimates, Raises '18 View
by Zacks Equity Research
U.S. Steel's (X) Q2 results surpass expectations. The company is optimistic about the success of its $2-billion asset revitalization program.
ArcelorMittal (MT) Q2 Earnings Rise Y/Y, Sales Top Estimates
by Zacks Equity Research
Higher steel selling prices and shipments boost ArcelorMittal's (MT) Q2 results.
CF Industries' (CF) Earnings, Revenues Top Estimates in Q2
by Zacks Equity Research
CF Industries (CF) gained from higher selling prices across its segments in Q2.
Univar's (UNVR) Earnings Trail, Sales Beat Estimates in Q2
by Zacks Equity Research
Univar (UNVR) reaffirmed its adjusted earnings guidance for full-year 2018.
Top 5 ROE Picks as Q2 Earnings Shine Despite Trade War Woes
by Supriyo Bose
ROE is often used to compare the profitability of a company with other firms in the industry - the higher, the better.